Clinical Trials Browser

Terminated × Semaxinib × Dermatologic × Clear all

NCT00006003 2013-01-24

SU5416 in Treating Patients With Metastatic Melanoma That Has Been Previously Treated

Phase 2 Terminated

Melanoma